Filing Details

Accession Number:
0001209191-12-006408
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-01-31 18:00:48
Reporting Period:
2012-01-27
Filing Date:
2012-01-31
Accepted Time:
2012-01-31 18:00:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1338042 Aegerion Pharmaceuticals Inc. AEGR Pharmaceutical Preparations (2834) 202960116
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1227759 Advent International Llc C/O Advent International Corporation
75 State Street, 29Th Floor
Boston MA 02109
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-01-27 49,448 $17.17 2,554,386 No 4 S Indirect See Footnote
Common Stock Disposition 2012-01-30 2,670 $17.06 2,551,716 No 4 S Indirect See Footnote
Common Stock Disposition 2012-01-31 22,054 $17.10 2,529,662 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. These securities are indirectly beneficially owned in the following capacity: as General Partner of AHLS III GP Limited partnership which in turn is the General Partner of Advent Healthcare and Life Sciences III Limited Partnership and Advent Healthcare and Life Sciences III-A Limited Partnership.